COMMUNIQUÉS West-GlobeNewswire

ChromaDex Appoints Lisa Bratkovich as Chief Marketing Officer

04/06/2018 - 12:30

IRVINE, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that it has appointed Lisa [...]

Teladoc Acquires Global Virtual Care Provider, Advance Medical

04/06/2018 - 12:30

Combination extends Teladoc’s global market leadership, strengthening and expanding company’s international footprint, breadth of medical services and physician network Patients and companies to benefit from a single, [...]

Teladoc Acquires Global Virtual Care Provider, Advance Medical

04/06/2018 - 12:30

Combination extends Teladoc’s global market leadership, strengthening and expanding company’s international footprint, breadth of medical services and physician network Patients and companies to benefit from a single, [...]

Orphazyme Presents at 2018 Parseghian Scientific Conference for Niemann-Pick Type C Research

04/06/2018 - 12:00

Orphazyme A/S Investor news No. 06/2018 Copenhagen, June 4, 2018 – Orphazyme A/S , a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that Orphazyme is [...]

Pluristem to Announce Top-Line Results of Its Multinational Phase II Intermittent Claudication Study on June 12, 2018

04/06/2018 - 12:00

HAIFA, Israel, June 04, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today announced that the top-line results of the [...]

Doug Disraeli D.D.S. Celebrates San Diego Pride Parade With LGBTQ Nonprofit Donations for New Appointments

04/06/2018 - 12:00

Hillcrest LGBTQ-friendly dentistry offers insight and support to make smiles stand out at Pride SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) -- In observance of the San Diego Pride Parade, Doug Disraeli D.D.S. supports [...]

Tetraphase Pharmaceuticals Announces Everest Medicines’ Submission of an Investigational New Drug Application for Eravacycline in Complicated Intra-Abdominal Infection to the China Food and Drug Administration

04/06/2018 - 12:00

WATERTOWN, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]

Amphastar Pharmaceuticals Receives FDA Approval for Semi-Purified Heparin at Amphastar Nanjing Pharmaceuticals

04/06/2018 - 12:00

RANCHO CUCAMONGA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration (“FDA”) granted approval of the company’s abbreviated new [...]

Corcept Therapeutics Announces Positive Relacorilant Data at the 2018 American Society of Clinical Oncology Meeting

04/06/2018 - 11:30

MENLO PARK, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ:CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe [...]

Chi-Med Presents Further Fruquintinib FRESCO Trial Data at ASCO 2018 Annual Meeting

04/06/2018 - 10:51

– Chi-Med makes additional FRESCO presentations at ASCO 2018, following oral presentation at ASCO 2017 showing that study met all endpoints with a manageable safety profile and lower off-target toxicities compared to [...]

Canada Health’s System Leaders Gather to Drive Improvement in Key Health Issues on June 4th and 5th, 2018 in St. John’s, NL

04/06/2018 - 10:30

ST. JOHN's, Newfoundland, June 04, 2018 (GLOBE NEWSWIRE) -- More than 700 health leaders, health policy experts and trustees will convene in St. John’s for the National Health Leadership Conference (NHLC) on June 4 th [...]

Terveystalo Plc: Managers' transactions - Von Rettig

04/06/2018 - 09:46

Terveystalo Plc, Managers' transactions, 4 June 2018 at 10:45 EEST ____________________________________________ Person subject to the notification requirement Name: Von Rettig, Tomas Position: Member of the Board/Deputy [...]

Terveystalo Plc: Managers' transactions - Viippola

04/06/2018 - 09:41

Terveystalo Plc, Managers' transactions, 4 June 2018 at 10:40 EEST ____________________________________________ Person subject to the notification requirement Name: Viippola, Katri Position: Member of the Board/Deputy [...]

Terveystalo Plc: Managers' transactions - Michelet

04/06/2018 - 09:36

Terveystalo Plc, Managers' transactions, 4 June 2018 at 10:35 EEST ____________________________________________ Person subject to the notification requirement Name: Michelet, Åse Position: Member of the Board/Deputy [...]

Terveystalo Plc: Managers' transactions - Holmström

04/06/2018 - 09:31

Terveystalo Plc, Managers' transactions, 4 June 2018 at 10:30 EEST ____________________________________________ Person subject to the notification requirement Name: Holmström, Olli Position: Member of the Board/Deputy [...]

Terveystalo Plc: Managers' transactions - Heinonen

04/06/2018 - 09:26

Terveystalo Plc, Managers' transactions, 4 June 2018 at 10:25 EEST ____________________________________________ Person subject to the notification requirement Name: Heinonen, Lasse Position: Member of the Board/Deputy [...]

Terveystalo Plc: Managers' transactions - Cappelen

04/06/2018 - 09:21

Terveystalo Plc, Managers' transactions, 4 June 2018 at 10:20 EEST ____________________________________________ Person subject to the notification requirement Name: Cappelen, Ulf Position: Member of the Board/Deputy [...]

Terveystalo Plc: Managers' transactions - Ahdekivi

04/06/2018 - 09:16

Terveystalo Plc, Managers' transactions, 4 June 2018 at 10:15 EEST ____________________________________________ Person subject to the notification requirement Name: Ahdekivi, Eeva Position: Member of the Board/Deputy [...]

PsiOxus Therapeutics Appoints Melissa Epperly as Chief Financial Officer

04/06/2018 - 09:00

PHILADELPHIA and OXFORD, United Kingdom, June 04, 2018 (GLOBE NEWSWIRE) -- PsiOxus Therapeutics, Ltd . (PsiOxus), a leader in gene therapy for cancer, today announced the appointment of Melissa Epperly as Chief [...]